Aguiar IL, Carvalho FM, Santos-Lins LS, Brasil-Oliveira R, Brites C, Cotrim HP, et al. Oral health related-quality of life before and during the COVID-19 pandemic in patients with non-alcoholic fatty liver disease. Med Oral Patol Oral Cir Bucal. 2023 Jul 1;28 (4):e310-6.
doi:10.4317/medoral.25731
https://dx.doi.org/doi:10.4317/medoral.25731
1. Melo CML, Silva GAS, Melo ARS, Freitas AC. COVID-19 pandemic outbreak: the Brazilian reality from the first case to the collapse of health services. An Acad Bras Cienc. 2020;92:e20200709. |
PMid:32844985 |
2. Chisini LA, De Castilhos AD, Costa FS, D'Ávila OP. Impact of the covid-19 pandemic on prenatal, diabetes and medical appointments in the Brazilian national health system. Rev Bras Epidemiol. 2021;24:e210013. |
PMid:34076088 |
3. Dos Santos MBF, Pires ALC, Saporiti JM, Kinalski MA, Marchini L. Impact of COVID-19 pandemic on oral health procedures provided by the Brazilian public health system: COVID-19 and oral health in Brazil. Health Policy Technol. 2021;10:135-42. |
PMid:33585171 PMCid:PMC7864786 |
4. Samuel SR, Kuduruthullah S, Khair AMB, Al Shayeb M, Elkaseh A, Varma SR, et al. Impact of pain, psychological-distress, SARS-CoV2 fear on adults' OHRQOL during COVID-19 pandemic. Saudi J Biol Sci. 2021;28:492-4. |
PMid:33132723 PMCid:PMC7588312 |
5. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease - Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73-84. |
PMid:26707365 |
6. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28:339-50. |
PMid:18956290 |
7. Furusho H, Miyauchi M, Hyogo H, Inubushi T, Ao M, Ouhara K, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol. 2013;48:1259-70. |
PMid:23307045 |
8. Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012;12:16. |
PMid:22340817 PMCid:PMC3305584 |
9. Lins, L. Bittencourt PL, Evangelista MA, Lins R, Codes L, Cavalcanti AR, etr al. Oral health profile of cirrhotic patients awaiting liver transplantation in the Brazilian northeast. Transplant Proc. 2011;43:1319-21. |
PMid:21620119 |
10. Aguiar I, Lins-Kusterer L, Lins LS, Paraná R, Bastos J, Carvalho FM. Quality of life, work ability and oral health among patients with chronic liver diseases. Med Oral Patol Oral Cir Bucal. 2019;24:e392-e7. |
PMid:31041917 PMCid:PMC6530952 |
11. Page RC, Eke PI. Case definitions for use in population- based surveillance of periodontitis. J Periodontol 2007;78:1387e99. |
PMid:17608611 |
12. Leroy E, Eaton KA, Savage A. Methodological issues in epidemiological studies of periodontitis - how can it be improved? BMC Oral Health. 2010;21:8. |
PMid:20409298 PMCid:PMC2874507 |
13. Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997;25:284-90. |
PMid:9332805 |
14. Lins-Kusterer L, Aguiar I, Santos-Lins LS, Lins-Rocha M, Aguiar CVN, Menezes MS, et al. Validation of the RAND 36-Item Health Survey questionnaire in Brazil. Arq Gastroenterol. 2022;59:193-7. |
PMid:35830028 |
15. Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80:99-103. |
PMid:12584072 |
16. Pautz N, Olivier B, Steyn F. The use of nonparametric effect sizes in single study musculoskeletal physiotherapy research: A practical primer. Phys Ther Sport. 2018;33:117-24. |
PMid:30077090 |
17. Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863. |
PMid:24324449 PMCid:PMC3840331 |
18. Li JC, Waisman RM. Probability of bivariate superiority: A non-parametric common-language statistic for detecting bivariate relationships. Behav Res Methods. 2019;51:258-79. |
PMid:30097805 |
19. Santos MBF, Pires ALC, Saporiti JM, Kinalski MA, Marchini L. Impact of COVID-19 pandemic on oral health procedures provided by the Brazilian public health system. Health Policy Technol. 2021;10:135-42. |
PMid:33585171 PMCid:PMC7864786 |
20. Bryson WJ. Long-term health-related quality of life concerns related to the COVID-19 pandemic: a call to action. Qual Life Res. 2021;30:643-5. |
PMid:33073307 PMCid:PMC7568937 |
21. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407-15. |
PMid:2691207 |
22. Poelemeijer YQM, van der Knaap ETW, Marang-van de Mheen PJ, Demirkiran A, Wiezer MJ, Hazebroek EJ, et al. Measuring quality of life in bariatric surgery: a multicentre study. Surg Endosc. 2020;34:5522-32. |
PMid:31993820 PMCid:PMC7644534 |
23. Strand V, Fiorentino D, Hu C, Day RM, Stevens RM, Papp KA. Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study. Health Qual Life Outcomes. 2013;11:82. |
PMid:23663752 PMCid:PMC3661377 |
24. Mouelhi Y, Jouve E, Castelli C, Gentile S. How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods. Health Qual Life Outcomes. 2020;18:136. |
PMid:32398083 PMCid:PMC7218583 |
25. King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res. 2011; 11:171-84. |
PMid:21476819 |
26. Yost KJ, Eton DT. Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof. 2005;28:172-91. |
PMid:15851772 |
27. Chisini, LA, Costa FS, Sartori LRM, Corrêa MB, D'Ávila OP, Demarco FF. COVID-19 pandemic impact on Brazil's public dental system. Braz Oral Res. 2021;35:1-11. |
PMid:34287465 |